Cargando…

Long-term mepolizumab treatment reduces relapse rates in super-responders with eosinophilic granulomatosis with polyangiitis

BACKGROUND: The mainstay of treatment for eosinophilic granulomatosis with polyangiitis (EGPA) is systemic corticosteroid therapy; some patients also receive intravenous immunoglobulins, other immunosuppressive agents, and biologics. Mepolizumab, an anti-interleukin-5 monoclonal antibody, induces re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masumoto, Nami, Oshikata, Chiyako, Nakadegawa, Ryo, Motobayashi, Yuto, Osada, Reeko, Manabe, Saki, Kaneko, Takeshi, Tsurikisawa, Naomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182616/ https://www.ncbi.nlm.nih.gov/pubmed/37179316 http://dx.doi.org/10.1186/s13223-023-00801-7

Ejemplares similares

Familial Eosinophilic Granulomatosis with Polyangiitis in a Sister and Brother
por: Ueki, Yuriko, et al.
Publicado: (2019)

Rituximab and dupilumab improve eosinophilic granulomatosis with polyangiitis with multiple pulmonary thrombi
por: Adachi, Sei, et al.
Publicado: (2022)

High-dose intravenous immunoglobulin therapy for eosinophilic granulomatosis with polyangiitis
por: Tsurikisawa, Naomi, et al.
Publicado: (2014)

A case of eosinophilic polyangiitis with granulomatosis that evolved to cardiac arrest due to advanced atrioventricular block
por: Sakurai, Yuichiro, et al.
Publicado: (2023)

Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
por: Portacci, Andrea, et al.
Publicado: (2023)

An increase of CD83(+) dendritic cells ex vivo correlates with increased regulatory T cells in patients with active eosinophilic granulomatosis and polyangiitis
por: Tsurikisawa, Naomi, et al.
Publicado: (2014)

Th17 cells reflect colon submucosal pathologic changes in active eosinophilic granulomatosis with polyangiitis
por: Tsurikisawa, Naomi, et al.
Publicado: (2015)

Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis
por: Pradhan, Ravi Ranjan, et al.
Publicado: (2019)

Pharmacogenetic investigation of efficacy response to mepolizumab in eosinophilic granulomatosis with polyangiitis
por: Condreay, Lynn D., et al.
Publicado: (2020)

Mepolizumab therapy improves endomyocarditis in seropositive eosinophilic granulomatosis with polyangiitis
por: Wang, Chrong-Reen, et al.
Publicado: (2022)

Concurrent Use of Mepolizumab and Rituximab for Eosinophilic Granulomatosis With Polyangiitis and Multisystem Involvement
por: Afiari, Agura, et al.
Publicado: (2020)

Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis
por: Ueno, Masanobu, et al.
Publicado: (2021)

Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
por: Bettiol, Alessandra, et al.
Publicado: (2021)

Successful Treatment With Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A Case Report
por: Toscano Peña, Andrés, et al.
Publicado: (2023)

Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With Polyangiitis
por: Vultaggio, Alessandra, et al.
Publicado: (2020)

A Pediatric Case of Relapsing Eosinophilic Granulomatosis with Polyangiitis Successfully Treated with Mepolizumab
por: Nara, Mizuho, et al.
Publicado: (2019)

Successful treatment with benralizumab in a patient with eosinophilic granulomatosis with polyangiitis refractory to mepolizumab
por: Menzella, Francesco, et al.
Publicado: (2021)

Successful Treatment with Mepolizumab for Coronary Spastic Angina Associated with Eosinophilic Granulomatosis with Polyangiitis
por: Takigawa, Yuki, et al.
Publicado: (2023)

Mepolizumab therapy in a pediatric patient with eosinophilic granulomatosis with polyangiitis associated with refractory myocarditis
por: Ulu, Kadir, et al.
Publicado: (2022)

Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype
por: Terrier, Benjamin, et al.
Publicado: (2023)

Characteristics and Disease Burden of Patients With Eosinophilic Granulomatosis With Polyangiitis Initiating Mepolizumab in the United States
por: Silver, Jared, et al.
Publicado: (2023)

Eosinophilic Granulomatosis with Polyangiitis
por: Shukla, Ratnakar, et al.
Publicado: (2022)

A Case of Effective Mepolizumab Induction Therapy for Severe Eosinophilic Granulomatosis with Polyangiitis Diagnosed by Eosinophilic Cholecystitis and Interstitial Nephritis
por: Hattori, Keita, et al.
Publicado: (2021)

Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study
por: Ueno, Masanobu, et al.
Publicado: (2022)

Effective treatment with mepolizumab in a patient with severe eosinophilic granulomatosis with polyangiitis complicated with small intestine perforation
por: Sato, Mari, et al.
Publicado: (2023)

COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis?
por: Özdemir, Bahar, et al.
Publicado: (2021)

Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy
por: Faverio, Paola, et al.
Publicado: (2018)

Improvement of peripheral neuropathy in a patient with antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis by additional mepolizumab
por: Kai, Yoshiro, et al.
Publicado: (2022)

Eosinophilic Granulomatosis with Polyangiitis: An Overview
por: Gioffredi, Andrea, et al.
Publicado: (2014)

Prevasculitic Eosinophilic Granulomatosis With Polyangiitis
por: Burtson, Kathryn M, et al.
Publicado: (2021)

Eosinophilic Variant of Granulomatosis With Polyangiitis
por: Fernandes, Rui L, et al.
Publicado: (2023)

Acute Cholecystitis Associated with Eosinophilic Granulomatosis with Polyangiitis That Responded to Glucocorticoid Therapy
por: Ozaka, Sotaro, et al.
Publicado: (2022)

Correction to: COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis?
por: Özdemir, Bahar, et al.
Publicado: (2021)

Eosinophilic Cholecystitis Associated with Eosinophilic Granulomatosis with Polyangiitis
por: Ito, Hiroyuki, et al.
Publicado: (2020)

A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis
por: Quan, Michele V., et al.
Publicado: (2018)

Eosinophilic Granulomatosis With Polyangiitis: Dissecting the Pathophysiology
por: Fagni, Filippo, et al.
Publicado: (2021)

Renal Involvement in Eosinophilic Granulomatosis With Polyangiitis
por: Doreille, Alice, et al.
Publicado: (2021)

Dupilumab-Associated Eosinophilic Granulomatosis With Polyangiitis
por: Persaud, Purnadeo, et al.
Publicado: (2022)

Renal involvement in eosinophilic granulomatosis with polyangiitis
por: Reggiani, Francesco, et al.
Publicado: (2023)

Improvement of Chronic Rhinosinusitis and Reduction of the Myeloperoxidase-Antineutrophil Cytoplasmic Antibody Titer in a Patient with Eosinophilic Granulomatosis with Polyangiitis by Additional Mepolizumab
por: Tamechika, Shin-ya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qtnpl1abil4ls2um0e5m5c1ml6